Neurodegenerative Diseases News and Research

RSS

Espresso compounds inhibit tau protein aggregation in preliminary in vitro tests

Whether enjoyed on its own or mixed into a latte, Americano or even a martini, espresso provides an ultra-concentrated jolt of caffeine to coffee lovers.

19 Jul 2023

The infection connection: investigating the impact on dementia risk, neuroimaging reveals

Researchers compared the association between neuroimaging markers of dementia and antibodies to common infection.

17 Jul 2023

DFG funds new clinical research unit to study autoimmune-mediated neurological diseases

How do neurological disorders arise that are caused, triggered, or influenced by antibodies? What better possibilities are there for diagnosis – and above all for treatment? These are the questions addressed by the new Clinical Research Unit "BecauseY" headed by Charité – Universitätsmedizin Berlin. Innovative treatment options will especially benefit patients who at first glance are not suspected of having an antibody-mediated neurological disease.

14 Jul 2023

Superagers more likely to have greater movement speed than typical older adults

People in their eighties who can recall everyday events and life experiences as well as someone 20 to 30 years younger – known as superagers – are also more likely to have greater movement speed than typical older adults.

13 Jul 2023

AI tool accurately counts brain lesions on MRI scans within seconds

An artificial intelligence (AI) tool developed at The University of Texas Health Science Center at San Antonio accurately counts brain lesions on MRI scans within seconds.

13 Jul 2023

U-M researchers develop animal-free method to produce brain organoids

Researchers at University of Michigan developed a method to produce artificially grown miniature brains -; called human brain organoids -; free of animal cells that could greatly improve the way neurodegenerative conditions are studied and, eventually, treated.

13 Jul 2023

British neuroscientist wins Hartwig Piepenbrock-DZNE Prize for contributions to dementia research

This year's "Hartwig Piepenbrock-DZNE Prize", endowed with 60,000 euros, goes to the British neuroscientist Alison Goate, DPhil. The award recognizes her outstanding contributions to research into Alzheimer's disease and frontotemporal dementia.

13 Jul 2023

Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership

Evotec SE today announced that Bristol Myers Squibb Company has exercised its option to enter into an exclusive global licence agreement.

From Evotec 13 Jul 2023

New AI-aided biosensor developed to detect neurodegenerative diseases

By combining multiple advanced technologies into a single system, EPFL researchers have made a significant step forward in diagnosing neurodegenerative diseases (NDDs) such as Parkinson's disease (PD) and Alzheimer's disease (AD).

12 Jul 2023

Scientists identify signal essential for blood-brain barrier formation

What makes the vital layer of protective cells around the brain and spinal cord -; the blood-brain barrier -; more or less permeable has been one of the more mystifying questions in neuroscience.

12 Jul 2023

Study provides unprecedented insights into the complexity of large-scale neural networks

That experiences leave their trace in the connectivity of the brain has been known for a while, but a pioneering study by researchers at the German Center for Neurodegenerative Diseases (DZNE) and TUD Dresden University of Technology now shows how massive these effects really are.

11 Jul 2023

Australian rainforest remedies: Scientists explore bioactive plant compounds as potential anti-neuroinflammatory agents

Research discusses the process of discovering anti-inflammatory and neuroprotective drugs from medicinal plants found in the Australian rainforest. It focuses on the pathways from the discovery of bioactive plants to the validation in an appropriate neuro-inflammatory mouse model, using some examples from their current research.

9 Jul 2023

Neurodegenerative Diseases News and Research

Espresso compounds inhibit tau protein aggregation in preliminary in vitro tests

The infection connection: investigating the impact on dementia risk, neuroimaging reveals

DFG funds new clinical research unit to study autoimmune-mediated neurological diseases

Superagers more likely to have greater movement speed than typical older adults

AI tool accurately counts brain lesions on MRI scans within seconds

U-M researchers develop animal-free method to produce brain organoids

British neuroscientist wins Hartwig Piepenbrock-DZNE Prize for contributions to dementia research

Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership

New AI-aided biosensor developed to detect neurodegenerative diseases

Scientists identify signal essential for blood-brain barrier formation

Study provides unprecedented insights into the complexity of large-scale neural networks

Australian rainforest remedies: Scientists explore bioactive plant compounds as potential anti-neuroinflammatory agents

Does the Mediterranean diet lower the incidence of type 2 diabetes among non-Mediterranean populations?

EPFL scientists develop an innovative method for reconstructing Tau fibrils

SPG-15: A Mother's Fight for a Gene Therapy Cure, Maddi's Story

Caffeine found to be most effective for treating birth asphyxia

Novel engineered approach makes protein aggregates amenable to spatial manipulations in cells

New method can track the complete activity of proteins in living cells

Promoting widespread use of brief assessment tools in primary care for early detection of cognitive impairment

Early hallucinations may indicate faster cognitive decline in patients with Parkinson's disease

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News